Eli Lilly (United States)

Pharma Industry · Indianapolis, United States

1177 researchers · 2016 publications (5-year) · 47 clinical trials (5-year)

Research topics: Glucose Metabolism Disorders, Diabetes Mellitus, Body Weight, Arthritis, Social Sciences, Pain, Neurocognitive Disorders, Dementia, Psychophysiology, Alzheimer Disease

Top journals: Adv Ther, Diabetes Obes Metab, Diabetes Ther, Dermatol Ther (Heidelb), Curr Med Res Opin

Clinical research areas: Body Weight, Obesity, Overnutrition, Nutrition Disorders, Overweight, Glucose Metabolism Disorders

Top researchers: Remick David, Collier David A (Top 1% worldwide in Schizophrenia Spectrum and Other Psychotic Disorders), Yang Dennis (Top 100 worldwide in Endoscopy), Nelson David R (Top 1% worldwide in Hepatitis), Fleisher Adam S (Top 1% worldwide in Neurocognitive Disorders), Leung Donmienne, Dassau Eyal (Top 1% worldwide in Diabetes Mellitus)

ScienceLeadR experts at this institution: Kristina S Boye, Nanette C Schloot

About ScienceLeadR: How it works · Top KOL ranking

{{ sectionLabels.bio }}

No public content here yet.

No public content here yet.

No public content here yet.

No public content here yet.

No public content here yet.